B
524828
vs
B
BSE Sensex 30
Over the past 12 months, BDH has outperformed BSE Sensex 30, delivering a return of +24% compared to the BSE Sensex 30's +7% growth.
Stocks Performance
524828 vs BSE Sensex 30
Performance Gap
524828 vs BSE Sensex 30
Performance By Year
524828 vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
BDH Industries Ltd
Glance View
BDH Industries Ltd. engages in the manufacturing of therapeutic formulations. The company is headquartered in Mumbai, Maharashtra. The company is also involved in the manufacturing of therapeutic formulations. The company offers a range of oral solid dosages (OSD) technologies. The company offers its products in various therapeutic classes, such as antifungal, antibiotics, anticancer, anti-diabetic, antidepressant, anti-ulcerant, antimalarial, anti-inflammatory, analgesic, antispasmodic, anti-tuberculosis, cardiovascular, dermatological, non-steroidal anti-inflammatory drugs, psychotropic, trichology, and vitamins and minerals. Its products include formulations, such as Fentanyl Citrate Injection USP, KALPANJAN Forte Pain Balm, Compound Magnesium Trisilicate Tablets BP, Alcoholic Iodine Solition BP, COLD Syrup, Dicyclomine Hydrochloride Injection, and Aciclovir Cream BP. Its specialty formulations include Morphine Sulphate Slow Release Tablets 15mg, Sulfasalazine Delayed release tablets U.S.P. 500mg, and Indomethacin Extended Release Capsules U.S.P. 75 mg.